Eurobio Scientific Société anonyme (EPA:ALERS)
21.90
-0.70 (-3.10%)
Jun 3, 2026, 4:47 PM CET
EPA:ALERS Revenue
In the year 2025, Eurobio Scientific Société anonyme had annual revenue of 168.60M EUR with 9.08% growth. Eurobio Scientific Société anonyme had revenue of 87.80M in the half year ending December 31, 2025, with 23.18% growth.
Revenue
168.60M
Revenue Growth
+9.08%
P/S Ratio
1.35
Revenue / Employee
491.53K
Employees
343
Market Cap
227.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 168.60M | 14.03M | 9.08% |
| Dec 31, 2024 | 154.56M | 23.92M | 18.31% |
| Dec 31, 2023 | 130.65M | -22.25M | -14.55% |
| Dec 31, 2022 | 152.90M | -32.42M | -17.49% |
| Dec 31, 2021 | 185.32M | -3.87M | -2.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Biosynex | 95.19M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.47M |
| Novacyt | 22.96M |
| Implanet | 12.47M |
| Mauna Kea Technologies | 8.91M |
| SpineGuard | 3.76M |